The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
Top Cited Papers
Open Access
- 1 March 2011
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 377 (9771) , 1096-1101.e2
- https://doi.org/10.1016/s0140-6736(11)60278-x
Abstract
No abstract availableKeywords
Funding Information
- Bupa Foundation
- Health Technology Assessment Programme
This publication has 12 references indexed in Scilit:
- Antifibrinolytic drugs for acute traumatic injuryPublished by Wiley ,2012
- Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialThe Lancet, 2010
- Antifibrinolytic therapy: new data and new conceptsThe Lancet, 2010
- Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortalityThrombosis Research, 2009
- The Coagulopathy of Trauma: A Review of MechanismsJournal of Trauma: Injury, Infection & Critical Care, 2008
- Acute Coagulopathy of Trauma: Hypoperfusion Induces Systemic Anticoagulation and HyperfibrinolysisJournal of Trauma: Injury, Infection & Critical Care, 2008
- Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusionPublished by Wiley ,2007
- Subgroup analysis and other (mis)uses of baseline data in clinical trialsThe Lancet, 2000
- Cause of death in clinical researchJournal of the American College of Cardiology, 1999
- Basis of antifibrinolytic therapyJournal of Clinical Pathology, 1980